Free Trial
NASDAQ:SRTS

Sensus Healthcare (SRTS) Stock Price, News & Analysis

Sensus Healthcare logo
$4.86 +0.16 (+3.40%)
As of 07/3/2025 02:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Sensus Healthcare Stock (NASDAQ:SRTS)

Key Stats

Today's Range
$4.64
$4.74
50-Day Range
$4.07
$5.13
52-Week Range
$4.01
$9.33
Volume
36,647 shs
Average Volume
191,513 shs
Market Capitalization
$79.90 million
P/E Ratio
48.60
Dividend Yield
N/A
Price Target
$11.67
Consensus Rating
Buy

Company Overview

Sensus Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

SRTS MarketRank™: 

Sensus Healthcare scored higher than 38% of companies evaluated by MarketBeat, and ranked 691st out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sensus Healthcare has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Sensus Healthcare has only been the subject of 1 research reports in the past 90 days.

  • Read more about Sensus Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Sensus Healthcare are expected to decrease by -28.13% in the coming year, from $0.32 to $0.23 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sensus Healthcare is 48.60, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.63.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sensus Healthcare is 48.60, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.58.

  • Price to Book Value per Share Ratio

    Sensus Healthcare has a P/B Ratio of 1.43. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Sensus Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    6.18% of the float of Sensus Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Sensus Healthcare has a short interest ratio ("days to cover") of 8.9.
  • Change versus previous month

    Short interest in Sensus Healthcare has recently decreased by 7.10%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Sensus Healthcare does not currently pay a dividend.

  • Dividend Growth

    Sensus Healthcare does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.18% of the float of Sensus Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Sensus Healthcare has a short interest ratio ("days to cover") of 8.9.
  • Change versus previous month

    Short interest in Sensus Healthcare has recently decreased by 7.10%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Sensus Healthcare has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • Search Interest

    Only 1 people have searched for SRTS on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Sensus Healthcare to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Sensus Healthcare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 8.90% of the stock of Sensus Healthcare is held by insiders.

  • Percentage Held by Institutions

    Only 25.30% of the stock of Sensus Healthcare is held by institutions.

  • Read more about Sensus Healthcare's insider trading history.
Receive SRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SRTS Stock News Headlines

"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
See More Headlines

SRTS Stock Analysis - Frequently Asked Questions

Sensus Healthcare's stock was trading at $6.92 at the beginning of the year. Since then, SRTS stock has decreased by 29.8% and is now trading at $4.86.

Sensus Healthcare, Inc. (NASDAQ:SRTS) announced its quarterly earnings data on Thursday, May, 15th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of $0.04 by $0.20. The business earned $8.34 million during the quarter, compared to the consensus estimate of $7.23 million. Sensus Healthcare had a trailing twelve-month return on equity of 3.34% and a net margin of 4.56%.
Read the conference call transcript
.

Sensus Healthcare (SRTS) raised $20 million in an initial public offering on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company served as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sensus Healthcare investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), CrowdStrike (CRWD), EMCOR Group (EME), e.l.f. Beauty (ELF) and Arista Networks (ANET).

Company Calendar

Last Earnings
5/15/2025
Today
7/05/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:SRTS
Employees
40
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.67
High Stock Price Target
$13.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+140.1%
Consensus Rating
Buy
Rating Score (0-4)
3.25
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
48.60
Forward P/E Ratio
15.19
P/E Growth
N/A
Net Income
$6.65 million
Pretax Margin
8.76%

Debt

Sales & Book Value

Annual Sales
$41.81 million
Cash Flow
$0.45 per share
Price / Cash Flow
10.79
Book Value
$3.41 per share
Price / Book
1.43

Miscellaneous

Free Float
14,981,000
Market Cap
$79.90 million
Optionable
Optionable
Beta
1.29

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:SRTS) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners